Drugplain

NDC 59417-119-01

Vyvanse 50 mg/1

LISDEXAMFETAMINE DIMESYLATE · TABLET, CHEWABLE

No Recall History

Vyvanse is a tablet, chewable containing lisdexamfetamine dimesylate at a strength of 50 mg/1. Manufactured by Takeda Pharmaceuticals America, Inc..

Key Facts

Brand Name
Vyvanse
Generic Name
LISDEXAMFETAMINE DIMESYLATE
NDC Code (Package)
59417-119-01
NDC Code (Product)
59417-119
Manufacturer
Takeda Pharmaceuticals America, Inc.
Strength
50 mg/1
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Marketing Status
DEA Schedule
Schedule II (Controlled)
Application #
NDA208510
Marketing Start
01/28/2017

Recall History

No Recall History

View Full Drug Page

Vyvanse — All Packages

Not medical advice. This information is for reference only. Always consult your doctor or pharmacist.